Altimmune ALT

$ 8.61 2.44%

Quarterly report 2024-Q3
added 11-12-2024

Altimmune EV/EBITDA Ratio 2011-2024 | ALT

Annual EV/EBITDA Ratio Altimmune

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-1.66	-6.54	-0.711	1.36	-0.958	13.8	17.2	1.38	0.677	1.43	0.981

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
17.2	-6.54	2.45